US Patent Issued to Hoffmann-La Roche on Dec. 30 for "CGAS inhibiting triazolopyrimidone derivatives" (Swiss, German Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,467, issued on Dec. 30, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"CGAS inhibiting triazolopyrimidone derivatives" was invented by Guido Galley (Rheinfelden, Germany), Katrin Groebke Zbinden (Liestal, Switzerland), Wolfgang Guba (Mullheim, Germany) and Daniel Hunziker (Mohlin, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a compound of formula (I), wherein R1-R3 and A1-A3 are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament."

The patent was filed on May 18, 2021, under Application No. 17/999,194.

*For further information, including imag...